These results further indicated that STAT3 signalling was involved in the progression of AngII‐induced cardiac hypertrophy, and PM reduced AngII‐induced cardiac hypertrophy by suppressing STAT3 activity, as determined from phosphorylation and nuclear translocation levels. This evidence concerns the gene STAT3 and cardiac hypertrophy.